`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`ABBVIE INC., et al.,
`
`Plaintiffs,
`
`v.
`
`DR. REDDY’S LABORATORIES, LTD., et
`al.,
`
`Defendants.
`ABBVIE INC., et al.,
`
`Plaintiffs,
`
` v.
`
`ALEMBIC PHARMACEUTICALS LTD.,
`ALEMBIC PHARMACEUTICALS, INC.,
`and ALEMBIC GLOBAL HOLDING SA,
`
`Defendants.
`
`C.A. No. 20-968 (MSG)
`
`C.A. No. 20-1009 (MSG)
`
`
`
`STIPULATION AND ORDER TO EXTEND TIME
`
`IT IS HEREBY STIPULATED AND AGREED, by and between Plaintiffs AbbVie Inc.
`
`and Genentech, Inc. and Defendants Dr. Reddy’s Laboratories, Ltd., Dr. Reddy’s Laboratories,
`
`Inc., Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., and Alembic Global Holding
`
`SA, and subject to the approval of the Court, that the following deadlines shall be extended as
`
`follows:
`
`Event
`Defendants serve initial
`invalidity contentions on the
`’649, ’942, and ’087 patents
`Parties identify terms for
`construction and the proposed
`constructions for newly
`asserted patents
`Parties submit Joint Claim
`Construction Statement
`
`Current Deadline
`January 18, 2022
`
`Revised Deadline
`February 4, 2022
`
`January 28, 2022
`
`February 14, 2022
`
`February 11, 2022
`
`February 28, 2022
`
`DRL EXHIBIT 1014 PAGE 1
`
`DRL EXHIBIT 1014 PAGE 1
`
`
`
`Case 1:20-cv-00968-MSG Document 88 Filed 01/18/22 Page 2 of 3 PageID #: 4154
`
`Event
`including newly asserted
`patents
`Simultaneous opening claim
`construction briefs and claim
`construction tutorial
`Simultaneous
`answering/responsive claim
`construction briefs
`Simultaneous reply claim
`construction briefs
`Markman hearing
`
`Current Deadline
`
`Revised Deadline
`
`March 9, 2022
`
`March 18, 2022
`
`April 12, 2022
`
`Unchanged
`
`May 3, 2022
`
`July 12, 2022
`
`Unchanged
`
`Unchanged
`
`All other deadlines set forth in the Amended Scheduling Order (D.I. 81) remain unchanged.
`
`Dated: January 13, 2022
`
`SAUL EWING ARNSTEIN & LEHR LLP
`
`SMITH, KATZENSTEIN & JENKINS LLP
`
`/s/ Aubrey J. Morin
`James D. Taylor, Jr. (No. 4009)
`Charles E. Davis (No. 6402)
`Jessica M. Jones (No. 6246)
`Aubrey J. Morin (No. 6568)
`1201 N. Market Street, Suite 2300
`Wilmington, DE 19899
`(302) 421-6800
`James.Taylor@saul.com
`Chad.Davis@saul.com
`Jessica.Jones@saul.com
`Aubrey.Morin@saul.com
`
`Attorneys for Plaintiffs AbbVie Inc. and
`Genentech, Inc.
`
`/s/ Eve H. Ormerod
`Neal C. Belgam (No. 2721)
`Eve H. Ormerod (No. 5369)
`1000 West Street, Suite 1501
`Wilmington, DE 19801
`(302) 652-8400
`nbelgam@skjlaw.com
`eormerod@skjlaw.com
`
`Attorneys for Defendants Dr. Reddy’s
`Laboratories, Ltd., and Dr. Reddy’s
`Laboratories, Inc.
`
`2
`
`DRL EXHIBIT 1014 PAGE 2
`
`DRL EXHIBIT 1014 PAGE 2
`
`
`
`Case 1:20-cv-00968-MSG Document 88 Filed 01/18/22 Page 3 of 3 PageID #: 4155
`
`YOUNG CONAWAY STARGATT
`& TAYLOR, LLP
`
`/s/ Samantha G. Wilson
`Anne Shea Gaza (No. 4093)
`Samantha G. Wilson (No. 5816)
`Rodney Square
`1000 North King Street
`Wilmington, DE 19801
`(302) 571-6600
`agaza@ycst.com
`swilson@ycst.com
`
`Attorneys for Defendants
`Alembic Pharmaceuticals Ltd.,
`Alembic Pharmaceuticals, Inc.,
`and Alembic Global Holding SA
`
`SO ORDERED this ____ day of _____________, 2022.
`18th
`January
`
`___________________________________
`/s/ Mitchell S. Goldberg
`United States District Judge
`
`3
`
`DRL EXHIBIT 1014 PAGE 3
`
`DRL EXHIBIT 1014 PAGE 3
`
`